EnteroTrack Developing and Commercializing Non-Invasive Device To Monitor Gastrointestinal Tract Inflammation

EnteroTrack Developing and Commercializing Non-Invasive Device To Monitor Gastrointestinal Tract Inflammation
EnteroTrack, LLC and the University of Colorado (CU) recently signed an exclusive agreement that will allow the company to develop and market a new monitoring device for gastrointestinal tract inflammation. The new technology could enhance current diagnostic and treatment approaches for a variety of GI diseases, including IBD, where inflammation is an issue. It is often difficult

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *